Prograf Generics Now on Equal Footing with Original Product

December 14, 2023
Companies manufacturing generic versions of Astellas Pharma’s immunosuppressant Prograf (tacrolimus) said on December 13 that their copycat products have earned a label expansion into the indication of interstitial pneumonia associated with polymyositis and dermatomyositis. The new indication was added to...read more